(Q42037016)

15 October 2017

Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors (English)

1 reference

15 October 2017

6

1 reference

15 October 2017

7

1 reference

15 October 2017

Stefano Barbi

3

0 references

Edoardo Missiaglia

object named as

Edoardo Missiaglia

series ordinal

2

0 references

Claudio Doglioni

object named as

Claudio Doglioni

series ordinal

5

0 references

Irene Dalai

series ordinal

1

object named as

Irene Dalai

1 reference

15 October 2017

Giovanni Butturini

4

1 reference

15 October 2017

1 March 2007

1 reference

15 October 2017

1 reference

15 October 2017

9

1 reference

15 October 2017

3

1 reference

15 October 2017

181-183

1 reference

Silencing of the maternally imprinted tumor suppressor ARHI contributes to follicular thyroid carcinogenesis

15 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838575

Molecular genetics of gastroenteropancreatic endocrine tumors.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838575

The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838575

ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838575

NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838575

Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838575

Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838575

Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1838575

Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy: A comparative study with proliferating-cell nuclear antigen and progesterone receptor protein immunostaining, mitotic index, and

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17401457

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Biochemistry and Biology of ARHI (DIRAS3), an Imprinted Tumor Suppressor Gene Whose Expression Is Lost in Ovarian and Breast Cancers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17401457

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of the tumor suppressor gene ARHI in epithelial ovarian cancer is associated with increased expression of p21WAF1/CIP1 and prolonged progression-free survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17401457

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1593/NEO.06838

1 reference

15 October 2017

1 reference

15 October 2017

1 reference

PMCID

1838575